$0.740
-0.018 (-2.49%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
BRNS-Prognose durch Analyse ähnlicher Charts
Alphio's BRNS stock price prediction model matches the current Barinthus Biotherapeutics PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.77 (+3.41%). The 1-week path is $0.78 (+5.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Barinthus Biotherapeutics PLC-Aktien kaufen?
Barinthus Biotherapeutics PLC is a good buy right now due to its recent positive price momentum, with a 5-day change of +6.18% and a projected final change of +90.79% based on historical patterns. The RSI of 58.83 indicates that the stock is neither overbought nor oversold, suggesting potential for further gains. However, the main risk is the company's net income, which has been negative, with a recent EPS of -0.26, indicating ongoing profitability challenges.
BRNS schloss am Tuesday bei $0.74, nachdem der Kurs -2.49% fallen
Barinthus Biotherapeutics PLC (BRNS) last closed at $0.7401, losing -2.49%. These facts feed the 1-day and 1-week BRNS price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Barinthus Biotherapeutics PLC (BRNS) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf BRNS am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für BRNS
Historically the probability of a positive November return for BRNS is 0.00%. October offers the highest probability of a positive month at 50.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für BRNS
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $1.25 | $1.39 | $1.66 | +88.00% |
| Dec 2026 | $1.59 | $1.81 | $2.00 | +144.34% |
Für 2026 wird für Barinthus Biotherapeutics PLC (BRNS) eine Spanne von $1.25 bis $2.00 projiziert.
Monatsprognose 2026 für Barinthus Biotherapeutics PLC
Im Nov 2026 wird für Barinthus Biotherapeutics PLC ein Durchschnitt von $1.39 erwartet, mit einem Tief von $1.25 und einem Hoch von $1.66.
Im Dec 2026 wird für Barinthus Biotherapeutics PLC ein Durchschnitt von $1.81 erwartet, mit einem Tief von $1.59 und einem Hoch von $2.00.
Ähnliche Artikel
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.